Clinical Trial Update: Evaluate the Efficacy and Safety of Different Doses of Edaravone Dexborneol Concentrated Solution for Injection Combined With Conventional Medical Therapy in the Treatment of Patients With Cerebral Hemorrhage [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluated the efficacy and safety of different doses of Edaravone Dexborneol Concentrated Solution for Injection plus conventional medical thera…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cerebral Hemorrhage

Drugs mentioned

• Edaravone Dexborneol Concentrated Solution for Injection (edaravone dexborneol)

Snippet

Sponsor: Simcere Pharmaceutical Co., Ltd | Conditions: Subjects With Cerebral Hemorrhage | Phase 2 | Status: TERMINATED